At Suanfarma CDMO (Contract Development & Manufacturing Organization) we provide integrated end-to-end solutions for development and commercialization of intermediates and drug substances for small molecules.
We are specialists helping pharmaceutical, biotech and healthcare companies, delivering the Core Values in CDMO and leading innovative integrated services that compress timelines to market maximizing success.
Our one-stop shop CDMO service is provided generating competitive advantages through two main axes: supply chain and value chain solutions.
Rating Reviews
Rating is calculated based on
1
review and is evolving.
Pros: The team environment is a major plus; colleagues are collaborative and always willing to share knowledge, which really helps in a dynamic contract manufacturing industry. I've gained valuable hands-on experience and exposure to various drug development projects. Management is generally approachable and supportive of professional development, making it a good place for career growth within the pharmaceutical sector.
Cons: Communication between departments can sometimes be slow, leading to minor delays on project timelines. Workload can become quite heavy during peak project phases, sometimes impacting work-life balance slightly. While benefits are decent, there's room for improvement in certain areas compared to larger pharmaceutical organizations. More structured career progression paths would be beneficial.
Advice to Management: Focus on streamlining inter-departmental communication and formalizing career advancement frameworks to retain talent and enhance overall efficiency in project delivery for clients.
Show more
What are some of the key benefits and aspects of the working culture at Suanfarma CDMO?
As a CDMO in the pharmaceutical industry, Suanfarma offers a range of benefits and fosters a collaborative working culture. Employees often mention the supportive environment and opportunities for professional growth within the company, which is important for roles in pharmaceutical manufacturing and development.
US
